Suppr超能文献

DL-[14C]普尼拉明在人体中的代谢。

Metabolism of DL-[14C]prenylamine in man.

作者信息

Remberg G, Eichelbaum M, Spiteller G, Dengler H J

出版信息

Biomed Mass Spectrom. 1977 Oct;4(5):297-304. doi: 10.1002/bms.1200040505.

Abstract

Following oral administration of DL-[14C]prenylamine, about 40% of the dose administered was excreted in urine within 10 days. Less than 0.1% of the dose was excreted as unchanged prenylamine. The drug was extensively metabolized to at least 20 to 25 metabolites. The structure of 12 metabolites could be elucidated by means of g.c.m.s. Ring hydroxylation and further methylation of the phenolic metabolites are the main metabolic pathways involved. A substantial part of the drug and/or its metabolites is metabolized via cleavage of the C--N--C bond, giving rise to amphetamine and diphenylpropylamine which are further metabolized by aromatic and sidechain hydroxylation.

摘要

口服DL-[14C]普尼拉明后,给药剂量的约40%在10天内随尿液排出。以原形普尼拉明形式排出的剂量不到0.1%。该药物被广泛代谢为至少20至25种代谢产物。12种代谢产物的结构可通过气相色谱-质谱联用(g.c.m.s.)来阐明。酚类代谢产物的环羟基化和进一步甲基化是主要的代谢途径。该药物和/或其代谢产物的很大一部分通过C--N--C键的断裂进行代谢,产生苯丙胺和二苯基丙胺,它们通过芳环和侧链羟基化进一步代谢。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验